# OPZELURA
> **NDA215309** · New Drug Application · Sponsor: INCYTE CORP · Approved 2021-09-21
## Drug
- **FDA Application Number:** NDA215309
- **Application type:** New Drug Application
- **Brand name:** OPZELURA
- **Generic name:** RUXOLITINIB
- **Active ingredients:** RUXOLITINIB PHOSPHATE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** INCYTE CORP
- **Manufacturer:** Incyte Corporation
- **First approval:** 2021-09-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215309)
---
*MORVS · CC0 1.0*